KTE-X19 bags FDA Priority Review in mantle cell lymphoma
admin 11th February 2020 Uncategorised 0The EMA also recently validated a Marketing Authorisation Application for the drug.
More: KTE-X19 bags FDA Priority Review in mantle cell lymphoma
Source: News